• Design lead for front-end engineering globally for biopharmaceutical drug substance and drug product. Support corporate strategy, project definition, business impact analysis, engineering service strategy, capital planning, and site allocations for a portfolio of projects > $1B. • Led the design definition and delivery of >$750M greenfield drug product facility for commercial and clinical medicine and vaccine products. Coordinated project from inception through funding to delivery including the integration of cross-enterprise processes (liquid, lyo, ADC), technology, dose forms, and operations. Organized and built internal team and procured external partners for successful execution.• Led the design definition and delivery of large biopharm and vaccine facility renovations for capacity expansion, manufacturing efficiency, and remediation for quality, safety, technology drivers. Multiple projects ranging in value from $10M - $125M.

• Director responsible for a team of 7+ managers and 70+ engineers supporting the process and facility of GSK’s first biopharmaceutical manufacturing plant. Member of the site leadership team. Responsible for an operating budget of $10M+, a capital budget of $15M+, and master planning strategy related to facilities, equipment, sustainability, and manufacturing.• Responsible to sponsor and deliver large site capital projects (new processes, expansions). Sponsor of multiple individual projects > $100M and a program >$350M during tenure. With long term stewardship and strategic vision, site produced triple its original capacity design at near 100% success rate and has reduced energy cost >60% despite a 100% increase in footprint. • Technical authority to develop, set direction, and manage the site functions of engineering, capital, maintenance, controls, energy, utilities, validation, and facility management and adherence to global engineering and EHS standards for all the above. • Accountable for overall effective maintenance of all process systems and facility systems. Identified, prioritized, and championed projects to improve system and equipment operational efficiencies, sustainability, reliability, and obsolescence.• Ensured facility operations compliance with various state and local permits, environmental regulations, and company standards.• Grew, developed, and increased team capability in compliance, digital, and maintenance management to a recognized GSK leading level.

• Strategy leader owning projects focusing on sterile and biopharmaceutical contract manufacturing. Projects included strategic supplier evaluation and selection, volume consolidation and optimization across regional partners, supplier exit negotiations, new business and new product procurement support, manufacturing technical problem solving, and supply management. • Negotiated pharmaceutical supply contracts, conducted due diligence, and developed strategic supplier agreements.• Experience evaluating suppliers in developing markets (MEA, LA, AP) for sterile and drug substance manufacturing. Fluent in technical requirements and facility evaluations to GSK standards.

• Manager responsible for the efforts and development of 8 engineers supporting the manufacture of biopharmaceutical products. Executed and delivered capital projects averaging $5M / year. • Accountable for support engineering of all process systems across two value streams – microbial equipment included 10kL fermenters and 2M chromatography systems and mammalian equipment included 5kL bioreactors. • Specialized in external business development efforts as engineering SME in capacity and fit evaluations. Developed proposals for external clients including financials, manufacturing schedules, and equipment/process evaluations.

• Project Manager supported the implementation of a biopharm product at the sterile drug product site specializing in lyophilized presentations. Managed budgets, designs, construction, commissioning, and validation of new equipment of value <$2M. • Developed capability to deliver a complex project in a new language and culture. Focus on contractor management and negotiation. • Gained fluency in sterile facility and equipment design principles and standards.

• Project Engineer supported the design, construction, qualification, and operation of a 10kL yeast fermentation process ($125M). Lead engineer responsible for coordination of all design, procurement, construction decisions amongst the GSK team and with all external partners. Interfaced with equipment suppliers, engineering firms, subcontractors, and end users. • Process Engineer supported the design, construction, qualification, and operation of a 5kL cell culture process at 5kL scale ($50M). Lead engineer for the upstream and utility areas.• After both projects, supported commercial manufacturing by solving operational, mechanical, reliability, or obsolescence issues.

Consulting engineer for Centocor (J&J) and Amgen. Supervised a team responsible for commissioning the a 15kL scale cell-culture facility. Designer for the purification areas of the 1kL scale perfusion cell-culture facility. Delivered equipment including chromatography skids, columns, UF/DF skids, autoclaves, and washers.

Consulting engineer for GSK and Lonza Biologics. Created and coordinated the commissioning and handover program for a 20kL scale cell-culture facility. Completed a product-specific CIP PQ program for a 5kL scale cell-culture facility. Performed IQ, OQ, and PQ protocols.